From: Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection
Well oral anti-HCV assay | OraQuick anti-HCV assay (n = 200) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Center 1 (n = 65) | Center 2 (n = 66) | Center 3 (n = 69) | Centers 1–3 (n = 200) | Total | |||||
Positive | Negative | Positive | Negative | Positive | Negative | Positive | Negative | ||
Positive, n | 24 | 0 | 27 | 1 | 22 | 1 | 73 | 2 | 75 |
Negative, n | 1 | 40 | 0 | 38 | 0 | 46 | 1 | 124 | 125 |
Total | 25 | 40 | 27 | 39 | 22 | 47 | 74 | 126 | 200 |
Consistency c(%) (95% CI) | 98.46(91.00,100.00) | 98.48(91.12,100.00) | 98.55(91.48,100.00) | 98.50(95.48,99.69) | |||||
Kappa valuec | 0.967 | 0.969 | 9.67 | 0.968 |